Matthew J Akiyama
Overview
Explore the profile of Matthew J Akiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
731
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phillips V, Pluznik J, Epting M, ODonovan E, Akiyama M, Spaulding A
AIDS Behav
. 2025 Mar;
PMID: 40080294
Approximately 1.5% of incarcerated people live with HIV. Limited information on their pre-incarceration healthcare use which could inform discharge planning efforts to link them to treatment is available. We investigate...
2.
Schneider I, Wallrafen-Sam K, Kennedy S, Akiyama M, Spaulding A, Jenness S
Infect Dis Model
. 2025 Mar;
10(2):628-638.
PMID: 40027595
Background: Airborne pathogens present challenges in settings like jails or prisons with a high density of contacts. The state of Georgia has the highest percentage of its citizens under correctional...
3.
Manley H, Riback L, Nyakowa M, Akiyama M, Cherutich P, Lizcano J, et al.
PLOS Glob Public Health
. 2025 Jan;
5(1):e0003284.
PMID: 39821143
Hepatitis C (HCV) disproportionately affects people who inject drugs (PWID). Despite availability of safe and effective treatment, HCV treatment access and uptake among PWID in low- and middle-income countries (LMICs)...
4.
Akiyama M, Thornton K, Voyles N, Vincent L
Clin Infect Dis
. 2024 Nov;
PMID: 39602404
No abstract available.
5.
Akiyama M, Bialek T, Simonson R
JAMA
. 2024 Nov;
333(5):369-370.
PMID: 39541137
No abstract available.
6.
Gormley M, Zhang W, Self S, Ewing J, Heo M, Roth P, et al.
J Subst Use
. 2024 Nov;
29(5):836-842.
PMID: 39502837
Background: Treating hepatitis C virus (HCV) in people who inject drugs (PWID) has been associated with increased health-related quality of life (HRQOL). Polysubstance use (PSU) is common among PWID, but...
7.
Coe J, Birnbaum J, Omarufilo F, Sigal S, Akiyama M
BMC Public Health
. 2024 Oct;
24(1):2985.
PMID: 39468488
Background: There is a high burden of hepatitis B virus (HBV) in West Africa. Over the past 20 years, West African immigration to the United States (U.S.) has been increasing....
8.
Kronfli N, Mambro A, Riback L, Ortiz-Paredes D, Dussault C, Chalifoux S, et al.
Int J Drug Policy
. 2024 Oct;
133:104624.
PMID: 39426103
Background: Patient navigation increases linkage to hepatitis C virus (HCV) care following release from prison; however, little is known about the services patient navigators should provide to maximize linkage to...
9.
Kennedy S, Saber L, Brown V, Boehm R, Olotu A, Osei J, et al.
Am J Public Health
. 2024 Oct;
114(11):1232-1241.
PMID: 39357007
To describe 4 unique models of operationalizing wastewater-based surveillance (WBS) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in jails of graduated sizes and different architectural designs. We summarize how...
10.
Padi A, Pericot-Valverde I, Heo M, Dotherow J, Niu J, Martin M, et al.
Viruses
. 2024 Aug;
16(8.
PMID: 39205278
This study is a secondary analysis of a randomized clinical trial (October 2013-April 2017) involving 150 People Who Inject Drugs (PWIDs) with hepatitis (HCV) seen in opioid agonist treatment programs...